Skip to main content
Top
Literature
1.
go back to reference Ryan K, Bain BJ, Worthington D et al (2010) Significant haemoglobinopathies: guidelines for screening and diagnosis. Br J Haematol 149(1):35–49CrossRefPubMed Ryan K, Bain BJ, Worthington D et al (2010) Significant haemoglobinopathies: guidelines for screening and diagnosis. Br J Haematol 149(1):35–49CrossRefPubMed
2.
go back to reference Bain BJ (2006) Other significant haemoglobinopathies. In: Bain BJ (ed) Haemoglobinopathy diagnosis, 2nd edn. Blackwell Publishing, Oxford, pp 190–233CrossRef Bain BJ (2006) Other significant haemoglobinopathies. In: Bain BJ (ed) Haemoglobinopathy diagnosis, 2nd edn. Blackwell Publishing, Oxford, pp 190–233CrossRef
3.
go back to reference Joutovsky A, Hadzi-Nesic J, Nardi MA (2004) Retention time as a diagnostic tool for hemoglobin variants and hemoglobinopathies: a study of 60,000 samples in a clinical diagnostic laboratory. Clin Chem 50:1736–1747CrossRefPubMed Joutovsky A, Hadzi-Nesic J, Nardi MA (2004) Retention time as a diagnostic tool for hemoglobin variants and hemoglobinopathies: a study of 60,000 samples in a clinical diagnostic laboratory. Clin Chem 50:1736–1747CrossRefPubMed
4.
go back to reference Colah RB, Surve R, Sawant P et al (2007) HPLC studies in hemoglobinopathies. Indian J Pediatr 74(7):657–662CrossRefPubMed Colah RB, Surve R, Sawant P et al (2007) HPLC studies in hemoglobinopathies. Indian J Pediatr 74(7):657–662CrossRefPubMed
5.
go back to reference Kumar M, Sharma P, Kumar V et al (2013) Continuing diagnostic relevance of the sickling test in the era of CE-HPLC. Indian J Hematol Blood Transfus 29(1):58–60CrossRefPubMed Kumar M, Sharma P, Kumar V et al (2013) Continuing diagnostic relevance of the sickling test in the era of CE-HPLC. Indian J Hematol Blood Transfus 29(1):58–60CrossRefPubMed
Metadata
Title
Reconfirming HPLC-Detected Abnormal Haemoglobins by a Second Independent Technique: A Judicious Approach
Authors
Jitender Mohan Khunger
Anita Chopra
Sadhna Arora
H. P. Pati
Publication date
01-06-2016
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue Special Issue 1/2016
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-014-0493-y

Other articles of this Special Issue 1/2016

Indian Journal of Hematology and Blood Transfusion 1/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine